Disease activity during pregnancy and pregnancy outcomes in patients with multiple sclerosis treated with Alemtuzumab – A case series from the German MS and Pregnancy Registry (P1.367)
Published in Neurology • Apr 18, 2017
Authors:
Kerstin Hellwig
,
Tjalf Ziemssen
,
Thorsten Rosenkranz
Abstract
1.to assess MS disease activity during pregnancy after alemtuzumab (ALZ) treatment.2.to document pregnancy outcomes in ALZ exposed pregnancies [ALZ<4 months after the last menstrual period (LMP)]
Disease activity during pregnancy and pregnancy outcomes in patients with multiple sclerosis treated with Alemtuzumab – A case series from the German MS and Pregnancy Registry (P1.367) | NobleBlocks
